False Positive Drug Test: Causes and What to Do Next
A false positive drug test can occur when a screening test reacts to a medication or another substance instead of the drug it is intended to detect. Certain antidepressants, cough medicines and antibiotics have been associated with this problem on specific urine screening assays. An unexpected result needs review before anyone draws conclusions about drug use.
It’s essential to understand the implications of a false positive drug test, as it can affect employment and legal issues.
A rapid cup provides a preliminary, or presumptive, result. A non-negative screen should be followed by appropriate laboratory confirmation and professional interpretation when the result will affect an important decision. The FDA explains the need to confirm preliminary home drug-test results before taking serious action.
Many factors contribute to a false positive drug test, so one should consult with professionals regarding any unexpected results.
This guide explains documented causes, common misconceptions and practical next steps for people being tested and organizations managing a screening program.
What Can Cause a False Positive Drug Test?
Many rapid urine tests use immunoassays: antibodies react to a target drug, metabolite or drug class. Sometimes another compound produces a reaction that the assay interprets as a non-negative result. This is called cross-reactivity.
Understanding cross-reactivity is vital to prevent a false positive drug test that can have serious consequences.
A false positive urine drug test is different from an unexpected result that correctly detects a substance. For example, a prescribed amphetamine may be detected by an amphetamine assay. A THC-containing hemp product may also lead to actual THC-metabolite detection. These situations need context, even when the analytical finding is correct.
Many people experience anxiety regarding a false positive drug test, which can lead to unnecessary stress.
The exact assay matters. A medication associated with interference in one testing system may not affect another. ARUP’s drug-testing guidance explains that immunoassay interference can depend on the assay, patient and specimen. A general medication list cannot establish what happened in an individual test.
Medications Associated With False Positive Drug Screens
Knowing the medications associated with a false positive drug test helps in navigating potential issues during screenings.
The examples below come from published studies of particular testing systems. They are reasons to investigate an unexpected finding, not proof that a medication caused it. They also do not establish cross-reactivity for every cup sold by DrugTestingCup.com.
| Medication | Screen potentially affected | Evidence and limitation |
|---|---|---|
| Bupropion | Amphetamines | Associated with unconfirmed amphetamine screens in a study using the Syva EMIT II assay. Bupropion study. |
| Sertraline | Benzodiazepines | A retrospective study found an association on a particular laboratory testing system. This does not apply automatically to every benzodiazepine assay. Sertraline study. |
| Dextromethorphan | PCP | This cough-suppressant ingredient was associated with PCP screens that failed confirmation in a hospital study. PCP screening study. |
| Tramadol | PCP | The same study found an association with unconfirmed PCP screens. Detection of tramadol by a dedicated tramadol assay is a separate question. Tramadol and PCP findings. |
Give the reviewing healthcare professional or Medical Review Officer the exact medication name, dose and timing, following the program’s confidential review process. Include combination cold medicines and supplements. A product’s brand name alone may not identify every active ingredient.
Do not stop or change prescribed medication to prepare for a drug test without speaking with your prescriber. Keep prescription information available for the appropriate reviewer.
Can Antibiotics Cause a False Positive Drug Test?
Antibiotics can sometimes lead to a false positive drug test, underscoring the importance of disclosing medication use.
Some antibiotics have interfered with specific immunoassays. Research on quinolone antibiotics found that levofloxacin, ofloxacin and certain related drugs could produce non-negative opiate screens on some of the systems studied. This is an assay-dependent finding, not a rule for every antibiotic. Read the quinolone interference study.
Amoxicillin should not be routinely blamed for a cocaine result. A study of people taking amoxicillin tested their urine with four screening assays and found that the cocaine-metabolite positive specimens were confirmed by GC-MS. The investigators concluded that amoxicillin was unlikely to cause a false-positive cocaine-metabolite screen under the conditions studied. Read the amoxicillin study.
When facing a false positive drug test, it’s crucial to consult with a healthcare provider about any recent medications.
If you take an antibiotic and receive an unexpected result, provide the drug name to the reviewer and ask whether the laboratory has evidence of interference with the exact assay used.
Can Ibuprofen Cause a False Positive Drug Test?
Understanding how ibuprofen can lead to a false positive drug test is key for those concerned about testing.
Older research reported occasional false-positive cannabinoid or barbiturate results with certain assays in people taking ibuprofen or naproxen. A prospective study published in 1990 found only a small likelihood of interference across the specimens examined. Those findings cannot establish how every current test will perform. Read the NSAID interference study.
Taking ibuprofen does not, by itself, explain an unexpected THC screen. The laboratory should consider the assay’s current documentation, the medication history and the confirmatory result.
Can Foods or CBD Products Affect Drug Test Results?
Poppy Seeds and Opiate Results
Poppy seeds can contain morphine and codeine residues. Controlled research has shown that consuming poppy seeds can produce measurable urinary opiates and results above certain testing cutoffs. The outcome depends on the seeds’ opiate content, amount consumed, collection timing and test threshold. See the controlled poppy-seed study.
This can involve real detection of morphine or codeine. A laboratory may confirm those compounds even when exposure came from food. Confirmation therefore answers an analytical question; the reviewing professional still needs to interpret the source and significance of the finding.
Record relevant food exposure if asked during review. Do not assume that every poppy-seed serving produces the same result or that a fixed waiting period guarantees a negative screen.
CBD, Hemp Products and THC Results
CBD products can potentially cause a false positive drug test, making it important to be fully informed of the ingredients.
A product marketed as CBD or hemp may also contain THC. Research comparing pure CBD with CBD-dominant cannabis found that pure CBD was unlikely to affect cannabis testing, while products containing relatively small amounts of THC could produce a cannabis-positive urine result. Read the Johns Hopkins research summary.
If THC metabolites are present, the finding can reflect actual exposure. It should not automatically be described as a false positive caused by CBD. Keep the packaging and ingredient information available for review, and tell the reviewing professional exactly which product was used.
Users must recognize that a false positive drug test could arise from substances marketed as CBD.
Could the Result Have Been Read Incorrectly?
The possibility of a false positive drug test should prompt individuals to verify results with reliable information.
Before investigating medication interference, check whether the device produced a valid result and whether it was interpreted correctly. On many competitive urine drug-test strips, a visible control line and a visible test line indicate a negative screen. A faint colored test line can still count as negative when it appears within the manufacturer’s reading window.
A missing control line makes the affected test invalid. An invalid result cannot be interpreted as evidence of drug use. Read our illustrated guide to how to read a drug test cup for the distinction between negative, non-negative and invalid results.
Always follow the insert for the exact device. Do not apply a pregnancy-test interpretation to a drug-screening strip or assume every product has the same reading time. Our Serenity Cup and test-format instructions explain why matching instructions to the device matters.
How Cutoff Levels Affect Interpretation
Cutoff levels in drug testing can significantly impact the likelihood of a false positive drug test result.
A cutoff is the concentration used to classify a result. A negative screen generally means the target was not detected at or above that assay’s threshold; it does not establish that the specimen contains absolutely none of the substance.
Two tests may use different thresholds or detect different compounds. Comparing results without checking those details can create confusion. Our drug test cutoff levels guide explains the terms to check on the product insert and laboratory report.
What to Do After an Unexpected Non-Negative Result
After an unexpected non-negative result, consider how a false positive drug test might influence the next steps.
Ask for a documented review instead of trying to identify the cause from an online list. A practical sequence is:
-
- Identify the finding. Ask which drug or metabolite was flagged, the specimen type and whether the result is an initial screen or a confirmed laboratory finding.
Identifying the specific circumstances surrounding a false positive drug test can aid in understanding your situation.
-
- Check the procedure. Ask whether the control line, reading window, expiration date and specimen identification were checked.
- Provide relevant information privately. Give the appropriate reviewer your medication list, prescription details and relevant supplement or food history.
- Ask about definitive testing. Discuss confirmation for the flagged substance and whether the original specimen is available under the program’s procedures.
Clarifying the review process after a false positive drug test is essential for addressing concerns.
- Clarify the review process. Ask who will interpret the laboratory findings, what documentation is needed and when to expect an update.
- Keep records. Retain the test report, specimen reference number and communications about the review.
ARUP’s unexpected-results algorithm recommends investigating unexpected findings, which may involve confirmation and/or a new specimen. Repeating a rapid screen does not provide the same information as a definitive laboratory method.
The role of Medical Review Officers is vital in investigating claims of a false positive drug test effectively.
In DOT-regulated testing, Medical Review Officers evaluate legitimate medical explanations and protect the confidentiality of testing information. Other programs may have different review procedures. DOT describes the Medical Review Officer’s role.
How Laboratory Confirmation Helps
Definitive methods such as GC-MS and LC-MS/MS identify specified drugs or metabolites more specifically than an immunoassay. They can help determine whether a screening reaction corresponds to the substance being investigated. The laboratory must select a method that includes the relevant analyte; a targeted test does not identify every possible substance.
Laboratory confirmation can help dispel concerns regarding a false positive drug test.
Confirmation is especially useful when an unexpected screening result could change treatment or another significant decision. A laboratory report still requires interpretation alongside prescriptions and other relevant information. ARUP explains presumptive and definitive testing.
For healthcare teams also reviewing the billing terminology, our CPT codes for presumptive and definitive drug testing guide explains those categories separately.
Testing programs that consider the risk of a false positive drug test can develop more reliable protocols.
How Testing Programs Can Reduce Avoidable Errors
Build a consistent workflow around the device and the follow-up process. A useful operational checklist includes:
Creating a checklist to address potential false positive drug test scenarios enhances overall testing reliability.
-
- Confirm the product’s intended use, specimen type, analytes and cutoffs before ordering.
- Keep the current instructions accessible to everyone performing tests.
- Check packaging, expiration dates and storage conditions before use.
- Use a timer and record results within the specified reading window.
- Document specimen identity and handling according to the program’s procedures.
- Arrange a laboratory referral and review pathway before an unexpected result occurs.
Specimen validity assessments can help mitigate the issues of a false positive drug test.
Specimen validity indicators answer another set of questions. Depending on the device, they may assess properties such as pH, specific gravity or creatinine. They do not confirm a particular drug. Our specimen validity and adulterants guide explains how these indicators fit into a testing program.
CLIA-waived status does not turn an immunoassay into a definitive laboratory test. CMS describes waived tests as simple tests with a low risk of an incorrect result; that classification is not a promise that errors are impossible. See the CMS explanation of test complexity.
Understanding the limitations of tests is key to addressing fears of a false positive drug test result.
When selecting supplies, compare urine drug test cups by the substances your program needs to screen and the exact product’s labeled use. If your setting requires a waived test, review the CLIA-waived drug test cup options and verify the status of the selected configuration.
When selecting supplies, consider how each may contribute to a false positive drug test in your testing program.
Frequently Asked Questions
Can a drug test be positive if I have not used illegal drugs?
Yes. Screening cross-reactivity, a prescribed medication or exposure through a THC-containing product can help explain an unexpected result. The cause must be assessed using the exact test, relevant history and appropriate laboratory confirmation.
Always consider how various factors can contribute to a false positive drug test when reviewing results.
Does taking a listed medication prove my result is false?
No. Published reports describe particular assays and circumstances. Taking a medication associated with interference does not establish the cause of your result. The reviewer needs the assay information and any relevant confirmatory findings.
The context of a false positive drug test is crucial in determining the necessary steps to take next.
Does a faint line mean a false positive drug test?
On many competitive urine drug-test strips, a visible colored test line counts as negative, even if faint, when the control line is present and the result is read on time. Follow the exact product insert.
Can another rapid cup confirm that the first result was wrong?
Another cup provides another screening result. A laboratory method such as GC-MS or LC-MS/MS supplies more specific information about the relevant drug or metabolite. Ask the reviewing professional which follow-up procedure is appropriate.
Laboratory confirmation is the most effective way to clarify a false positive drug test result.
Should I stop my prescription before a drug test?
Do not stop or change prescribed medication without speaking with your prescriber. Follow the testing program’s process for providing medication information to the appropriate healthcare professional or Medical Review Officer.
Can a drug test show whether someone is impaired?
A qualitative urine screening result alone does not establish current impairment, the dose taken or the exact time of use. Interpretation requires the testing context and qualified professional review. ACMT explains these limitations for urine THC testing.
